← Open Payments lookup

STEPHEN MENENDEZ: Open Payments

NPI 1962052407 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$749 in 40 payments from 14 companies in 2025. Trend: 2023 $712 · 2024 $559 · 2025 $749

Food & beverage: $749
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$173
E.R. Squibb & Sons, L.L.C.4$82
Janssen Pharmaceuticals, Inc4$78
Otsuka America Pharmaceutical, Inc.4$77
Indivior Inc.3$56
Neurocrine BioSciences, Inc.2$49
Teva Pharmaceuticals USA, Inc.2$46
Supernus Pharmaceuticals, Inc.1$45
Vanda Pharmaceuticals Inc.1$39
Lundbeck LLC1$27

Products named: CAPLYTA, COBENFY, ABILIFY ASIMTUFII, SUBLOCADE, INVEGA SUSTENNA, INGREZZA, REXULTI, Qelbree.

Industry payments across LA — which companies pay providers there.